Theodore Lau is a Cardiology physician. OpenAlex indexes 25 publications with 298 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1802 Yakima Ave Ste 307
Tacoma, WA 984055305
Telephone
253-627-1244Provider last certified this registry record 15 Sept 2021.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biosense Webster, Inc.Program year20255 payments
- Boston Scientific CorporationProgram year20242 payments
- Abbott LaboratoriesProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.5%Statin22%Atorvastatin Calcium63%Rosuvastatin Calcium31%Pravastatin Sodium3%Simvastatin2%Lovastatin1%Pitavastatin Calcium1%Part D<11 patientsBeta blocker16.4%Carvedilol49%Metoprolol Succinate35%Metoprolol Tartrate14%Atenolol2%Part D<11 patients+ 20 more classes in this area
Blood & clotting
15.7%Factor Xa inhibitor8.4%Eliquis69%Xarelto31%Part D≥102 patientsP2Y12 inhibitor6.9%Clopidogrel96%Brilinta4%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.5%Potassium supplement1.1%Potassium Chloride100%Part D≥23 patientsSGLT2 inhibitor0.4%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Uncommon Anomalous Biodistribution of <sup>18</sup>F-DCFPyL Prostate-Specific Membrane Antigen: A Case Series
Journal of Nuclear Medicine
2025 - A Novel “Telescopic Locking” Technique for Precise Stent Placement in the Ostium of the Left Anterior Descending Artery
Catheterization and Cardiovascular Interventions
2025 - BACK WITH A BLOCK! MERKEL CELL CARCINOMA RECURRENCE WITH HIGH GRADE AV BLOCK
Journal of the American College of Cardiology
2024 - An up‐to‐date review of cardiac pacemakers and implantable cardioverter defibrillators
Journal of Medical Imaging and Radiation Oncology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”